首页 | 本学科首页   官方微博 | 高级检索  
     


Patenting of hybridomas and genetically engineered microorganisms
Authors:H. Boyd Woodruff  Brinton M. Miller
Affiliation:(1) Merck Sharp & Dohme Research Laboratories Division, MSD (Japan) Co., Ltd., Tokyo, Japan;(2) Merck Sharp & Dohme Research Laboratories Division, Merck & Co., Inc., Rahway, New Jersey
Abstract:Summary Many new technologies arrived at through basic research have practical applications. Two recent breakthroughs in microbiology, recombinant DNA techniques and hybridoma techniques, will permit designing cells for specific practical purposes resulting in new products or functions of commercial significance. The unique cell or its usefulness, or both, may satisfy the requirements of a patentable invention, i.e. an inventive act having utility and novelty. Ownership of such patents permits recovery of expenses incurred in the invention process and investment for all concerned in additional research. An integral part of the patenting process is submission of the new cell to an official repository, an outstanding example of which is The American Type Culture Collection.
Keywords:patenting  engineered cells  repository  hybridoma  recombinant DNA
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号